Limpid, an AI-driven pet healthcare startup, announced on May 14 that it has signed a multilateral memorandum of understanding (MOU) with five domestic organizations for the development of a precision nutrition management platform based on multimodal AI for intractable complex diseases in companion animals.
This agreement was initiated following the selection of the “Technology Development Project for Overcoming Intractable Diseases in Companion Animals,” a national research and development (R&D) project for 2026. The five participating organizations are Sookmyung Women’s University, Kyungpook National University, Korea Testing Certification (KTC), and LV Veterinary Clinical Center, among others.
These institutions plan to closely collaborate on the early diagnosis (digital biomarkers) and commercialization of precision nutrition therapy solutions targeting four major intractable complex diseases—urinary, digestive, obesity/metabolic, and cardiovascular—using video AI technology.
Limpid – a Korean AI-driven pet healthcare company announced a new multi-organization collaboration focused on:
- AI-based precision nutrition
- multimodal disease management
- complex companion-animal disorders.
The initiative aims to develop:
- AI-assisted healthcare management systems
- precision nutrition platforms
- integrated pet disease analytics.
Industry participants increasingly believe:
- AI
- predictive diagnostics
- wearable pet monitoring
- digital veterinary platforms
will become core components of future companion-animal healthcare systems.
Key emerging applications include:
- obesity management
- dermatology monitoring
- chronic kidney disease tracking
- oncology support
- nutrition optimization.
In April 2026 – Limpid annoouned that it has been selected as the lead research institution for the “2026 Intractable Disease Overcoming Technology Development Project for Companion Animals,” organized by the Ministry of Agriculture, Food and Rural Affairs, South Korea.
